Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

36781 Press Releases
DateTitleCompany
23 Jun 17 NeuroMetrix Provides Update on Quell Wearable Pain Relief Clinical Program NeuroMetrix, Inc.,
Published by
Business Wire
23 Jun 17 Kadmon to Present Interim Data on KD025 in Chronic Graft-Versus-Host Disease (cGVHD) at R&D Day Kadmon Holdings, Inc.,
Published by
Business Wire
23 Jun 17 Catabasis Pharmaceuticals to Present Results from the MoveDMD® Trial of Edasalonexent (CAT-1004) at the 2017 PPMD Annual Connect Conference Catabasis Pharmaceuticals, Inc.,
Published by
Business Wire
23 Jun 17 Alexion Receives Positive CHMP Opinion for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG) in the European Union Alexion Pharmaceuticals, Inc.,
Published by
Business Wire
23 Jun 17 Enanta Announces that AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6) Enanta Pharmaceuticals, Inc.,
Published by
Business Wire
23 Jun 17 Syros Presents Data at EHA Supporting Potential of SY-1425, Its First-in-Class Selective RARa Agonist, in Genomically Defined AML and MDS Patients Syros Pharmaceuticals, Inc.,
Published by
Business Wire
23 Jun 17 European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes Gilead Sciences, Inc.,
Published by
Business Wire
23 Jun 17 Halyard Health Announces CEO Transition Halyard Health, Inc.,
Published by
PR Newswire
23 Jun 17 Entrinsic Health Solutions Announces Data from Poster Presentation at ISSN Annual Meeting Entrinsic Health Solutions, Inc.,
Published by
PR Newswire
23 Jun 17 bluebird bio Presents New Data from HGB-205 Study of LentiGlobinTM Drug Product in Patients with Transfusion-Dependent ß-Thalassemia (TDT) and Severe Sickle Cell Disease (SCD) at European Hematology Association (EHA) Annual Meeting bluebird bio, Inc.,
Published by
Business Wire
23 Jun 17 ArQule Presents Preclinical Data for BTK Inhibitor, ARQ 531, at the 22nd Annual Congress of the European Hematology Association (EHA) ArQule, Inc.,
Published by
Business Wire
23 Jun 17 bluebird bio Announces Early Data from Phase 3 Northstar-2 (HGB-207) Study of LentiGlobinTM Drug Product at European Hematology Association (EHA) Annual Meeting bluebird bio, Inc.,
Published by
Business Wire
22 Jun 17 FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies Thermo Fisher Scientific Inc.,
Published by
PR Newswire
22 Jun 17 Ocular Therapeutix™ Announces Executive Transition Plans Ocular Therapeutix, Inc.,
Published by
Business Wire
22 Jun 17 Pfizer Declares 32-Cent Third-Quarter 2017 Dividend Pfizer Inc.,
Published by
Business Wire
22 Jun 17 Robert J. Hennessey Appointed Chairman of the Board of Nanotherapeutics Nanotherapeutics, Inc.,
Published by
Business Wire
22 Jun 17 StemoniX® Wins Red Herring Top 100 Award StemoniX, Inc.,
Published by
PR Newswire
22 Jun 17 Exactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems Exactech, Inc.,
Published by
Business Wire
22 Jun 17 Merck and Premier Inc. Expand Collaboration to Address Chronic Care and Vaccination Rates Premier Inc.,
Published by
Business Wire
22 Jun 17 Alzheon Publishes New Analyses Showing Clinical Benefit of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer’s Disease; Clinical Effects Suggest Disease Modification and Align with Beta Amyloid Oligomer Formation Alzheon, Inc.,
Published by
Business Wire
22 Jun 17 Alzheon to Present Novel Molecular Mechanism of Action and Long Term Clinical Efficacy Data for Lead Candidate ALZ-801 at the Alzheimer’s Association International Conference Alzheon, Inc.,
Published by
Business Wire
22 Jun 17 RowdMap, Inc. Joins Aetna, Humana, United Healthcare, and Memorial Health System at the Georgia Society for Managed Care Summer Conference RowdMap, Inc.,
Published by
PR Newswire
22 Jun 17 Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg Lannett Company, Inc.,
Published by
PR Newswire
22 Jun 17 Cerner and Cloudera Win Ovum's Inaugural IoT Futures Award Cloudera, Inc.,
Published by
PR Newswire
22 Jun 17 Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017 Ionis Pharmaceuticals, Inc.,
Published by
PR Newswire
22 Jun 17 Minerva Announces Completion of Bridging Study to Select Improved Formulation of MIN-101 for Use in Phase 3 Trial for the Treatment of Negative Symptoms in Patients With Schizophrenia Minerva Neurosciences, Inc.,
Published by
GlobeNewswire
22 Jun 17 Manhattan Scientifics Announces Successful Completion of its Affiliate Imagion Biosystems IPO Manhattan Scientifics Inc.,
Published by
Business Wire
22 Jun 17 22nd Century Receives Guidance from FDA on Phase III Clinical Trials 22nd Century Group, Inc.,
Published by
Business Wire
22 Jun 17 Regeneron Details Royalty Agreement with Novartis for Canakinumab (ACZ885) Regeneron Pharmaceuticals, Inc.,
Published by
PR Newswire
22 Jun 17 Entrinsic Health Solutions Announces Data from Poster Presentation at MASCC Annual Meeting Entrinsic Health Solutions, Inc.,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.